Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Veena Fauble"'
Autor:
Allison Gathany, Richard J. Butterfield, Robyn M. Scherber, Christine Wolschke, Amylou C. Dueck, Holly L. Geyer, Veena Fauble, Jeanne Palmer, Nicolaus Kroeger, Heidi E. Kosiorek, Ruben A. Mesa
Publikováno v:
Biol Blood Marrow Transplant
Background: Myelofibrosis (MF) is a bone marrow disorder characterized by anemia, splenomegaly and constitutional symptoms. There has been substantial work documenting quality of life (QoL) in patients with MF, however, very little data about patient
Autor:
Jose F. Leis, Katie L. Kunze, Nandita Khera, Vivek Roy, Tania Jain, Mrinal M. Patnaik, William J. Hogan, Heidi E. Kosiorek, Pierre Noel, Jeanne Palmer, Ruben A. Mesa, Lisa Sproat, Luke Mountjoy, Daniel K. Partain, James L. Slack, Veena Fauble, Ayalew Tefferi
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 3, Pp 1-8 (2020)
Blood Cancer Journal, Vol 10, Iss 3, Pp 1-8 (2020)
Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to study such factors that can help identify patients at a higher risk of relapse
Autor:
Katie L. Kunze, Tania Jain, Daniel K. Partain, William J. Hogan, M'hamed Temkit, Veena Fauble, Lisa Z. Sproat, Vivek Roy, Jeanne Palmer, Mrinal S. Patnaik, Pierre Noel, James L. Slack, Jose F. Leis, Nandita Khera, Ruben A. Mesa
Publikováno v:
Bone Marrow Transplant
The aim of this study is to compare clinical outcomes of patients who underwent allogeneic stem cell transplantation (HCT) for myelofibrosis with reduced intensity conditioning (RIC) using either Busulfan Fludarabine (BuFlu), Fludarabine Bis-chloreth
Publikováno v:
Cancer Genetics. 220:13-18
Myeloid neoplasms with eosinophilia associated with PDGFRA rearrangement are very responsive to tyrosine kinase inhibitors (TKIs). Herein, we report a case of a 53-year-old man with eosinophilia and a well-differentiated extramedullary myeloid tumor
Autor:
Devora Delman, Riccardo Valdez, Nanna Hansen, James M Bogenberger, Ruben A. Mesa, Veena Fauble, Raoul Tibes
Publikováno v:
Leukemia & Lymphoma. 56:226-229
Novel targeted therapies for the treatment of acute myeloid leukemia (AML) and other advanced myeloid malignancies are urgently needed. Recently we reported results from in vitro studies comparing ...
Autor:
Craig B. Reeder, James L. Slack, Jared Klein, Jeffery A. Betcher, Roberta H. Adams, Jose F. Leis, Pierre Noel, Nandita Khera, Veena Fauble, Lisa Sproat, Amylou C. Dueck
Publikováno v:
Biology of Blood and Marrow Transplantation. 19:1167-1174
Although reduced-intensity conditioning has become standard of care for patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation (HCT), the optimum regimen has yet to be defined, and may depend on pretransplanta
Publikováno v:
Managing Myeloproliferative Neoplasms: A Case-Based Approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9db540fb15e91afe096f5aa5a4c29e6
https://doi.org/10.1017/cbo9781316017852.012
https://doi.org/10.1017/cbo9781316017852.012
Autor:
Chad Cherington, Ruben A. Mesa, Jane Olsen, Meagan S. Higgins, Roberta H. Adams, Veena Fauble, Jose F. Leis, Pierre Noel, Lisa D. Tremblay, James L. Slack, Jeffrey Betcher, John K. Camoriano, Raoul Tibes, Mary E Peterson, Ginger Gillette-Kent, Craig B. Reeder, Joseph R. Mikhael
Publikováno v:
Leukemia Research. 36:1147-1151
The prognosis for patients with Philadelphia-negative myeloproliferative neoplasms (MPN) who evolve into acute myeloid leukemia (AML) or blast phase (MPN-BP) is extremely poor. Although allogeneic stem cell transplantation (allo-SCT) is considered po
Publikováno v:
Leukemia Supplements. 1:S2-S7
The myeloproliferative neoplasm, myelofibrosis (MF), has only one therapeutic intervention that is potentially curative in these individuals, specifically that of allogeneic stem cell transplantation (ASCT). ASCT has been utilized up to this juncture
Autor:
M'hamed Temkit, Jeanne Palmer, Pierre Noel, Jose F. Leis, Ruben A. Mesa, James L. Slack, Veena Fauble, Nandita Khera, William J. Hogan, Daniel K. Partain, Vivek Roy, Lisa Z. Sproat, Mrinal S. Patnaik, Tania Jain
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S280-S281